上海金畔生物科技有限公司代理Takara Clontech酶试剂盒全线产品，欢迎访问官网了解更多产品信息和订购。

人iPS细胞
品牌	Code No.	产品名称	包装量	价格（元）	说明书	数量
Cellartis	Y00275	Cellartis® human iPS cell line 7 (ChiPSC7) Kit	1 Kit	￥23,108
Cellartis	Y00285	Cellartis® human iPS cell line 12 (ChiPSC12) Kit	1 kit	￥23,108
Cellartis	Y00315	Cellartis® human iPS cell line 21 (ChiPSC21) Kit	1 Kit	￥23,108
Cellartis	Y00325	Cellartis® human iPS cell line 22 (ChiPSC22) Kit	1 kit	￥23,108
Cellartis	Y00305	Cellartis® human iPS cell line 18 (ChiPSC18) Kit	1 Kit	￥23,108

人iPS细胞 (Human Induced Pluripotent Stem Cells)

Cellartis人iPS细胞（Human iPS Cell Line）产品是达到了工业客户使用标准生产的干细胞产品。该产品包括细胞和用于增殖培养的Cellartis DEF-CS Culture System培养体系。iPS细胞已经在制品化时完成了对DEF-CS培养体系的适应。Cellartis DEF-CS Culture System培养体系是组分明确而且不依赖饲养层的便捷的干细胞培养体系。Cellartis DEF-CS Culture System适合高效率地增殖培养干细胞，并且保持干细胞在增殖过程中几乎无分化地生长，这使得不需要在大规模增殖培养过程中进行细胞筛选。因此，Cellartis人iPS细胞（Human iPS Cell Line）产品是一套完整的产品体系，对于科研级别和工业规模的需求都适合。   ■ 产品特点 · Cell lines were created by reprogramming human skin fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, SOX2, KLF4, and c-Myc · Cell lines are extensively analyzed for purity and stem-cell characteristics, including recovery after thawing, absence of mycoplasma and bacteria, expression of stem cell-specific markers (Oct-4, NANOG, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81), absence of differentiation markers (Beta-3 tubulin, FOXA2, ASMA), and expected karyotype · Optimized for culture with the Cellartis DEF-CS Culture System · Suitable for all major applications; cells can form derivatives of all three germ layers when differentiated · Kits include the Cellartis DEF-CS 100 Culture System

■ 关联产品

Code No. Product Size Y30010 Cellartis® DEF-CS™ 500 Culture System 1 Kit

■ 产品详情请点击：

Characteristics of Cellartis human iPS cells. The cell lines were generated from fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, Sox-2, KLF-4, and c-Myc. The skin fibroblasts were obtained from donors of varying age and gender, have a normal karyotype, and have been confirmed to differentiate into specific cell lineages. Consent was obtained from all donors for commercial use.

参考文献：

1. de Peppo GM, et al. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A.2010 Nov;16(11):3413-3426. 2. Both SK, et al. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med.2011 Mar;5(3):180-190. 3. de Peppo GM, et al. Free-form-fabricated commercially pure Ti and Ti6A14V Porous Scaffolds support the growth of human embryonic stem cell-derived mesodermal progenitors. ScientificWorldJournal. 2012;2012:646417.Epub 2012 Jan 4. 4. Ou Li, et al. Human embryonic stem cell-derived mesenchymal stroma cells(hES-MSCs) engraft in vivo and support hematopoiesis without suppression immune function: implications for off –the shelf ES-MSC therapies. PLOS ONE.2013; 8(1):e55319.